芩胆咳喘康治疗急性支气管炎临床研究

Clinical Study of Qindankechuankang Tablets in Treating Acute Bronchitis

目的 观察芩胆咳喘康片对急性支气管炎的临床疗效。方法 治疗组应用芩胆咳喘康治疗急性支气管炎100例，并与用头孢氨苄胶囊、复方甘草合剂治疗者60例作对照观察。结果 治愈率及总有效率方面，治疗组分别为81％、95％，对照组为51.67％、85％，2组比较有显著性差异(P<0.01或<0.05)；2组治疗前后病情积分及主要症状起效时间方面，治疗组均优于对照组(P<0.01或<0.05)；治疗组中医证类疗效比较，风热证优于风寒证及风燥证(P<0.01)。结论 芩胆咳喘康治疗风热证急性支气管炎安全有效。

Objective:To observe the clinical effect of Qindankechuankang tablets in the treatment of Acute Bronchitis.Methods:160 patients with acute bronchitis were divided randomly into two groups:the treating group(n=100)received Qindankechuankang tablets,while the control group(n=60)received the Cefalexin capsules and the Brown mixture.Results:In the aspects of the entirely Healed ratio and total effective ratio, the treating group were 81％and 95％,while the control group were 51.67％and 85％.There are remarkable difference between the two groups(P<0.01 or <0.05). About the score of symptom and the taking effect time before and after treatment,the treating group is better than the control group(P<0.01 or <0.05). In the treating group,contrasted to the three TCM syndrome types, the effect of the wind－heat syndrome is better than that of the wind－cold syndrome or the wind－dry syndrome(P<0.01) Conclusion:Qindankechuankang tablets are safe and effective to acute Bronchitis (wind－heat syndrome).